|
Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial. |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; GlaxoSmithKline; Ipsen; Lilly; Pfizer; PharmaMar; Roche |
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Pfizer |
Research Funding - AstraZeneca |
Travel, Accommodations, Expenses - Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pierre Fabre; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Pfizer; Roche |
|
|
Honoraria - Bristol-Myers Squibb; Eisai; Eusa Pharma; Janssen-Cilag; Merck; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Janssen-Cilag; PharmaMar; Roche; Sanofi |
Other Relationship - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Grunenthal; Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Janssen |
Speakers' Bureau - Astellas Pharma; Janssen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Presurgy (I) |
Stock and Other Ownership Interests - Medisuntech SLU (I) |
Honoraria - Medisuntech SLU (I) |
Consulting or Advisory Role - AngioDynamics |
Travel, Accommodations, Expenses - GP Pharm; Ipsen; Janssen; Presurgy |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |